Insider track record Other Across 17 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Discover the full record of transactions filed by Julie Brown. Officer active across 1 company, notably GSK plc. In total, 54 filings have been logged. History available since 23 June 2023. The latest transaction was filed on 9 June 2026 (Purchase). Regulator: RNS (LSE). All data is openly available.
Declarations 54 total
● Chief Financial Officer · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:9614374-1 Ideal exit: 6 Mar 2027 (T+270) ● Chief Financial Officer · Executives · 9 Jun 2026 · GSK plc 14 shares @ £18.8393 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:03338973-0058-4811-9fe5-7b22157346a2-1 Ideal exit: 6 Mar 2027 (T+270) ● Chief Financial Officer · Executives · 12 May 2026 · GSK plc 14 shares @ £18.6557 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:eaad27f1-a91f-4bc4-815a-149202956de0-1 Ideal exit: 6 Feb 2027 (T+270) ● Chief Financial Officer · Executives · 27 Apr 2026 · GSK plc 243,880 shares 0
GB00BN7SWP63⌘ RNS:4a0e6e48-fd78-4de5-a74a-ff4879a0f254 ● Chief Financial Officer · Executives · 14 Apr 2026 · GSK plc 1,553 shares @ £21.67 0.0001% mcap 0.2% of flow GB00BN7SWP63⌘ RNS:ca89baf1-aabf-4020-b0fe-d5c65c1b3a57-1 ● Chief Financial Officer · Executives · 13 Apr 2026 · GSK plc 10 shares @ £21.709 0.0000% mcap 0.0% of flow GB00BN7SWP63⌘ RNS:bae2311e-28b0-4835-a894-0209eedccba9-1 Ideal exit: 8 Jan 2027 (T+270) ● Chief Financial Officer · Executives · 10 Mar 2026 · GSK plc 12 shares @ £20.7167 0.0% of flow GB00BN7SWP63⌘ RNS:08be650c-10c4-4fa5-9cae-5b89efa04716-1 Ideal exit: 5 Dec 2026 (T+270) ● Chief Financial Officer · Executives · 12 Feb 2026 · GSK plc 55,178 shares @ £21.50 7.2% of flow GB00BN7SWP63⌘ RNS:6207777f-2477-470b-868f-21f92714189a-1 ● Chief Financial Officer · Executives · 12 Feb 2026 · GSK plc 196,548 shares @ £21.50 25.6% of flow GB00BN7SWP63⌘ RNS:586c5c74-54b9-425a-a37c-ba21836ecce7-1 ● Chief Financial Officer · Executives · 10 Feb 2026 · GSK plc 12 shares @ £21.7917 0.0% of flow GB00BN7SWP63⌘ RNS:f7024c14-f781-4e48-a904-495085bc7ca2-1 Ideal exit: 7 Nov 2026 (T+270) ● Chief Financial Officer · Executives · 9 Jan 2026 · GSK plc 1,106 shares @ £18.91 0.1% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-25 ● Chief Financial Officer · Executives · 12 Jan 2026 · GSK plc 14 shares @ £18.9321 0.0% of flow GB00BN7SWP63⌘ RNS:07b8fade-09b6-4441-a582-c78ac4e1b6b3-42 Ideal exit: 9 Oct 2026 (T+270) ● Chief Financial Officer · Executives · 9 Dec 2025 · GSK plc 12 shares @ £18.0783 0.0% of flow GB00BN7SWP63⌘ RNS:58b71e9c-e0b4-4fdd-8b21-5f1119d38ddd-1 Ideal exit: 5 Sept 2026 (T+270) ● Chief Financial Officer · Executives · 11 Nov 2025 · GSK plc 14 shares @ £18.1421 0.0% of flow GB00BN7SWP63⌘ RNS:802a4789-60c0-4a7f-a34b-b750f1d9f048-1 Ideal exit: 8 Aug 2026 (T+270) ● Chief Financial Officer · Executives · 10 Oct 2025 · GSK plc 1,264 shares @ £16.40 0.2% of flow GB00BN7SWP63⌘ RNS:5862277-1 ● Chief Financial Officer · Executives · 9 Oct 2025 · GSK plc 16 shares @ £16.4081 0.0% of flow GB00BN7SWP63⌘ RNS:5857218-1 Ideal exit: 6 Jul 2026 (T+270) ● Chief Financial Officer · Executives · 9 Sept 2025 · GSK plc 16 shares @ £14.8575 0.0% of flow GB00BN7SWP63⌘ RNS:5815851-1 Ideal exit: 6 Jun 2026 (T+270) ● Chief Financial Officer · Executives · 11 Aug 2025 · GSK plc 18 shares @ £14.0844 0.0% of flow GB00BN7SWP63⌘ RNS:5777526-1 Ideal exit: 8 May 2026 (T+270) ● Chief Financial Officer · Executives · 10 Jul 2025 · GSK plc 1,409 shares @ £14.545 0.2% of flow GB00BN7SWP63⌘ RNS:5737340-20 ● Chief Financial Officer · Executives · 9 Jul 2025 · GSK plc 18 shares @ £14.2072 0.0% of flow GB00BN7SWP63⌘ RNS:5737340-1 Ideal exit: 5 Apr 2026 (T+270) ● Chief Financial Officer · Executives · 10 Jun 2025 · GSK plc 16 shares @ £14.9462 0.0% of flow GB00BN7SWP63⌘ RNS:202506120600PR_NEWS_UKDISCLO_0053-1 Ideal exit: 7 Mar 2026 (T+270) ● Chief Financial Officer · Executives · 12 May 2025 · GSK plc 20 shares @ £13.5075 0.0% of flow GB00BN7SWP63⌘ RNS:5652536-1 Ideal exit: 6 Feb 2026 (T+270) ● Chief Financial Officer · Executives · 16 Apr 2025 · GSK plc 1,588 shares @ £12.75 0.2% of flow GB00BN7SWP63⌘ RNS:5622701-1 ● Chief Financial Officer · Executives · 9 Apr 2025 · GSK plc 20 shares @ £12.6155 0.0% of flow GB00BN7SWP63⌘ RNS:5615070-1 Ideal exit: 4 Jan 2026 (T+270) ● Chief Financial Officer · Executives · 11 Mar 2025 · GSK plc 16 shares @ £15.4538 0.0% of flow GB00BN7SWP63⌘ RNS:5575192-1 Ideal exit: 6 Dec 2025 (T+270) 25 of 54 declarations
Load more (29 remaining) About Julie Brown Julie Brown is a declarant who has made 54 filings in total. In her most recent filings, she has made purchases of shares totaling 744154 euros, with no sales. The first filing date is June 23, 2023, and the last is scheduled for June 12, 2026. The amounts of the largest filings include 4907508.27 euros on February 21, 2025, and 4847225.66 euros on February 16, 2026.